Peer review reports
From: Mirabegron for overactive bladder in frail patients 80 years or over (HOKUTO study)
Original Submission | ||
---|---|---|
31 Oct 2021 | Submitted | Original manuscript |
8 Nov 2021 | Author responded | Author comments - Hiroshi Nakagomi |
Resubmission - Version 2 | ||
8 Nov 2021 | Submitted | Manuscript version 2 |
11 Nov 2021 | Author responded | Author comments - Hiroshi Nakagomi |
Resubmission - Version 3 | ||
11 Nov 2021 | Submitted | Manuscript version 3 |
16 Nov 2021 | Reviewed | Reviewer Report - Hamed Mohseni-Rad |
17 Nov 2021 | Reviewed | Reviewer Report |
21 Nov 2021 | Reviewed | Reviewer Report |
17 Dec 2021 | Author responded | Author comments - Hiroshi Nakagomi |
Resubmission - Version 4 | ||
17 Dec 2021 | Submitted | Manuscript version 4 |
17 Jan 2022 | Reviewed | Reviewer Report - Hamed Mohseni-Rad |
24 Jan 2022 | Reviewed | Reviewer Report |
1 Feb 2022 | Reviewed | Reviewer Report |
15 Feb 2022 | Author responded | Author comments - Hiroshi Nakagomi |
Resubmission - Version 5 | ||
15 Feb 2022 | Submitted | Manuscript version 5 |
9 Mar 2022 | Author responded | Author comments - Hiroshi Nakagomi |
Resubmission - Version 6 | ||
9 Mar 2022 | Submitted | Manuscript version 6 |
Publishing | ||
10 Mar 2022 | Editorially accepted | |
21 Mar 2022 | Article published | 10.1186/s12894-022-00989-7 |